<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03519087</url>
  </required_header>
  <id_info>
    <org_study_id>2017H0340</org_study_id>
    <nct_id>NCT03519087</nct_id>
  </id_info>
  <brief_title>Nonarthritic Hip Disease Evaluation And Treatment</brief_title>
  <acronym>NEAT</acronym>
  <official_title>Informed Decisions and Patient Outcomes: An Interdisciplinary Approach to Chronic Hip Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Foundation for Physical Therapy, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to understand how interdisciplinary care influences decisions,
      expectations, and outcomes for patients with non-arthritic hip disease (NAHD). Patients
      presenting to the Ohio State University Wexner Medical Center (OSUWMC) Hip Preservation
      Clinic will be approached for participation. All participants will proceed with their
      scheduled, standard-care physician evaluation. Participants without NAHD will be excluded.
      Participants will then be randomized to receive a same-day physical therapist (PT)
      evaluation. This PT evaluation is not a standard-care practice in the clinic, this was added
      for research. All participants will complete expectation surveys before and after their
      evaluation(s). The clinicians will discuss their recommended plan with the patient and the
      patient will record a final treatment decision and outcome expectations. Participants will
      then be randomized to either receive posture and movement training (PMT) for 3 weeks or
      undergo a 3-week wait period. All participants will be required to withhold any treatment
      during this 3-week period (except PMT in the PMT group). The 3-week wait period for the
      no-PMT group is aligned with current clinical processes for time from physician evaluation to
      start of treatment. All participants may proceed with any further interventions (including
      PMT) after the 3-week period, but none will be provided/required as part of research.
      Patient-reported outcomes and clinical tests will be recorded before and after the 3-week
      period, and 3 and 6 months later. Adding a PT evaluation to the physician visit provides no
      additional risk because the PT evaluation includes similar clinical tests to the physician
      and movement analysis during tasks participants complete during daily life. Clinical tests
      before/after the 3-week intervention period may produce muscle soreness that should resolve
      within 2 days. Understanding how interdisciplinary care influences expectations and outcomes
      can inform clinicians regarding the effectiveness of interdisciplinary collaboration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The clinical evaluation by the physician is standard-of-care and performed as part of
      potential participants' scheduled appointment. Participants in this study will complete a
      HIPAA authorization to allow data from their clinical evaluation by the physician to be
      utilized for this study, including any imaging the physician used in their clinical
      evaluation and the evaluation note entered into the participant's electronic health record.
      The physician notes are standardized, allowing streamlined data analysis from the electronic
      health record.

      Research activities to occur the same day as the informed consent process include
      randomization to receive or not receive a clinical evaluation by a physical therapist along
      with surveys for treatment decisions, expected outcomes, and patient-reported function. A
      small sub-group of patients will also complete interviews to identify how they felt about
      their evaluation that day. The HIPAA authorization will also allow the data from the physical
      therapy evaluation and any subsequent posture and movement training at OSUWMC to be utilized
      for this study.

      Regardless of randomization to receive or not receive a same-day physical therapy evaluation
      in the physician clinic, all participants will be randomized to receive posture and movement
      training (PMT) or undergo a 3-week wait period. Participants who are randomized to receive
      PMT as part of this research study will schedule based on their availability, twice weekly
      for 3 weeks with an OSUWMC Sports Medicine physical therapist who also hold IRB-approved
      status as research personnel. Participants will be made aware during the informed consent
      process that any PMT they receive as part of this study will be their responsibility to pay
      for using either self-pay or insurance-based methods.

      Participants who refuse randomization to receive PMT will be offered to participate in the
      observational group. These participants proceed with the same baseline and follow-up testing,
      but continue with their treatment-of-choice rather than an assigned treatment during the
      3-week intervention period.

      All participants will complete baseline and follow-up biomechanical and clinical follow-up
      testing in the Motion Analysis and Performance Laboratory. Biomechanical testing involves
      using 3-dimensional motion capture techniques to analyze movement during 3 functional tasks
      including walking, sit-to-stand, and a forward tap-down. Clinical testing involves obtaining
      anthropometric measures, hip strength, patient-reported function, and planned treatment
      decisions with respective expected outcomes. A small sub-group of patients will also complete
      interviews at these testing sessions to identify how they feel about the intervention (wait
      or posture &amp; movement training).

      Posture and movement training involves the physical therapist prescribing therapeutic
      exercises and activities to improve posture and movement (Harris-Hayes 2016), focusing
      heavily on extrinsic cueing (Benjaminse 2015). Therapeutic exercises and activities will be
      individualized based on the participant's presentation and will progress according to pain
      and quality of movement from double-leg to single-leg activities and from functional to more
      dynamic tasks.

      Participants who are randomized to undergo a 3-week wait period will be required to withhold
      any treatment during the 3-week wait period. These participants will complete the same
      testing as the participants in the PMT group (see next paragraph). These participants will
      not receive any intervention during the 3-week wait period; however, after their first
      follow-up testing session (within 1 week of completing the 3-week wait period), these
      participants may proceed with any intervention of their choice. The participants in the PMT
      group may also proceed with any intervention after their first follow-up testing session.
      These follow-up interventions will not be provided or required as part of the research study,
      but participants will be asked to report if they completed any follow-up interventions
      between their first follow-up testing session and their 3month and 6month follow-up testing
      sessions.

      Follow-up testing will occur within 1-week of completing the 3-week intervention period. At
      this point, participants in both the PMT and no-PMT groups may proceed with any intervention
      (i.e. surgery, injection, physical therapy). All participants will perform additional
      follow-up testing at 3- and 6-months post-intervention.

      Qualitative interviews will be conducted to evaluate how physicians and physical therapists
      involved in the study feel about the evaluation and treatment protocols.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The planned 15-month recruitment period was completed.
  </why_stopped>
  <start_date type="Actual">February 27, 2018</start_date>
  <completion_date type="Actual">May 31, 2019</completion_date>
  <primary_completion_date type="Actual">May 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment Plan</measure>
    <time_frame>Post-evaluation, same-day (approximately 5-10min after evaluation)</time_frame>
    <description>Participants will indicate their planned treatment(s)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Decisional Conflict</measure>
    <time_frame>Pre-evaluation, 10min Post-evaluation</time_frame>
    <description>Participants will report decisional conflict related to their treatment plan. Decisional conflict was measured using the Decisional Conflict Scale ranging from 0 (no conflict, better outcome) to 100 (high conflict, worse outcome).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Themes From Provider Interviews</measure>
    <time_frame>Pre-enrollment (2-7days before patient participant recruitment began), Post-enrollment (1-7 days after patient participant recruitment ended)</time_frame>
    <description>Qualitative interviews will be conducted with study providers both before patient participant enrollment and after study completion to collect information on how they feel about the evaluation protocols. Qualitative analysis of this data will count responses based on themes. Data for this report will be provided as the total number of responses (across all providers) that fell within each theme at both time points. Each provider could provide multiple responses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participant Protocol Opinions</measure>
    <time_frame>20min post-evaluation, 4 weeks post-evaluation</time_frame>
    <description>Participants will be interviewed to collect information on how they feel about the 1) evaluation protocol(s) and 2) treatment/wait period protocols.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decisional Conflict</measure>
    <time_frame>10min post-evaluation, 4-week laboratory visit</time_frame>
    <description>Participants will report decisional conflict related to their treatment plan. Decisional conflict was measured using the Decisional Conflict Scale ranging from 0 (no conflict, better outcome) to 100 (high conflict, worse outcome). Baseline scores for participants in Period 3 (Laboratory testing) were obtained from participants' post-evaluation surveys from Period 1 (clinic evaluation).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported Hip Function</measure>
    <time_frame>10min post-evaluation, 4-week laboratory visit</time_frame>
    <description>Participants will complete validated, reliable surveys for hip function (the Hip Outcome Score Activities of Daily Living [HOSADL] was used and is scored from 0-100 with 0 representing the worst function and 100 representing the best function). Baseline scores for participants in Period 3 (Laboratory testing) were obtained from participants' post-evaluation surveys from Period 1 (clinic evaluation).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Movement Mechanics</measure>
    <time_frame>Baseline laboratory visit, 4-week laboratory visit</time_frame>
    <description>3-dimensional movement mechanics will be collected during functional tasks including walking and rising from a chair</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Decisional Regret</measure>
    <time_frame>Day of enrollment, after all evaluations are complete</time_frame>
    <description>Participants will report decision regret related to their treatment plans</description>
  </other_outcome>
  <other_outcome>
    <measure>Decisional Regret</measure>
    <time_frame>4 weeks</time_frame>
    <description>Participants will report decision regret related to their treatment plans</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in Hip Strength</measure>
    <time_frame>4 weeks</time_frame>
    <description>Strength of hip abductors, adductors, flexors, extenders, internal and external rotators will be collected during maximal voluntary isometric contractions</description>
  </other_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">112</enrollment>
  <condition>Clinical Decision Making</condition>
  <condition>Nonarthritic Hip Disease</condition>
  <arm_group>
    <arm_group_label>Interdisciplinary Evaluation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive an Interdisciplinary Evaluation for Nonarthritic Hip Disease from a hip arthroscopist, followed by an examination from a physical therapist, and then will participate in a shared decision-making process with both providers to determine a plan of care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Evaluation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will receive a standard-of-care evaluation from a hip arthroscopist who will then determine the plan of care with the participant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Posture and Movement Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive six training sessions with a physical therapist over a 3-week period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3-week Wait Period</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will undergo a 3-week wait period. They will be instructed to not receive any treatment (e.g. chiropractic services, physical therapy, medication, surgery, injections) for their hip symptoms during this time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Observational Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants who refuse randomization to receive posture and movement training may continue participation in an observational group. These participants complete the same baseline and follow-up testing but proceed with their treatment-of-choice during the 3-week intervention period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interdisciplinary Evaluation for Nonarthritic Hip Disease</intervention_name>
    <description>The hip arthroscopist will conduct his or her standard-care evaluation including subjective interview, patient history, imaging, and physical examination. The physical therapist will conduct an assessment of posture and movement during sitting, standing, squatting, and walking. After providers discuss their findings, they will discuss the plan of care with the participant.</description>
    <arm_group_label>Interdisciplinary Evaluation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Posture and Movement Training</intervention_name>
    <description>Physical therapists will lead participants through an intervention protocol to normalize seated and standing posture and function movement. Verbal, visual, and tactile cues, along with strengthening exercises will be provided to train posture and movement.</description>
    <arm_group_label>Posture and Movement Training</arm_group_label>
    <other_name>Movement Pattern Training</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment-of-choice</intervention_name>
    <description>Participants may proceed with any treatment-of-choice, which may or may not have been recommended by their health care provider(s). Treatments will be recorded, but not controlled.</description>
    <arm_group_label>Observational Arm</arm_group_label>
    <other_name>Standard care</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Over 18 years old NAHD diagnosis

        Exclusion Criteria:

          -  Osteoporosis or rheumatoid arthritis

          -  Systemic health condition

          -  Legal representative required for treatment decisions

          -  Bilateral symptoms

          -  Current spine, hip, knee, or ankle surgery or major injury*

          -  Pregnancy

          -  Total hip arthroplasty candidate (TÃ¶nnis grade &gt; 2)

          -  Periacetabular osteotomy candidate (lateral center edge angle&lt;20, anterior center edge
             angle&lt;18, acetabular index &gt;10)

               -  Participants with history of spine, hip, knee, or ankle surgery or major injury
                  will be evaluated by the physician to determine appropriateness for evaluation
                  (and treatment) by a physical therapist
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephanie Di Stasi, PhD, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center Jameson Crane Sports Medicine Institute</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 27, 2018</study_first_submitted>
  <study_first_submitted_qc>April 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2018</study_first_posted>
  <results_first_submitted>October 8, 2019</results_first_submitted>
  <results_first_submitted_qc>May 5, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">May 6, 2020</results_first_posted>
  <last_update_submitted>May 5, 2020</last_update_submitted>
  <last_update_submitted_qc>May 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Stephanie Di Stasi</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>At this time, our IPD will be shared with researchers listed on the funding mechanisms for this project. When submitting manuscripts, IPD will be available upon request.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 14, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/87/NCT03519087/Prot_003.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 20, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/87/NCT03519087/SAP_004.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 6, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/87/NCT03519087/ICF_005.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>No participants were excluded from the study before assignment to groups (interdisciplinary vs. standard)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Interdisciplinary Evaluation</title>
          <description>Participants will receive an Interdisciplinary Evaluation for Nonarthritic Hip Disease from a hip arthroscopist, followed by an examination from a physical therapist, and then will participate in a shared decision-making process with both providers to determine a plan of care.
Interdisciplinary Evaluation for Nonarthritic Hip Disease: The hip arthroscopist will conduct his or her standard-care evaluation including subjective interview, patient history, imaging, and physical examination. The physical therapist will conduct an assessment of posture and movement during sitting, standing, squatting, and walking. After providers discuss their findings, they will discuss the plan of care with the participant.</description>
        </group>
        <group group_id="P2">
          <title>Standard Evaluation</title>
          <description>Participants will receive a standard-of-care evaluation from a hip arthroscopist who will then determine the plan of care with the participant.</description>
        </group>
        <group group_id="P3">
          <title>Posture and Movement Training</title>
          <description>Participants will receive six training sessions with a physical therapist over a 3-week period.</description>
        </group>
        <group group_id="P4">
          <title>3-week Wait Period</title>
          <description>Participants will undergo a 3-week wait period. They will be instructed to not receive any treatment (e.g. chiropractic services, physical therapy, medication, surgery, injections) for their hip symptoms during this time.</description>
        </group>
        <group group_id="P5">
          <title>Observational Arm</title>
          <description>Participants who refuse randomization to receive posture and movement training may continue participation in an observational group. These participants complete the same baseline and follow-up testing but proceed with their treatment-of-choice during the 3-week intervention period.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Clinic Evaluation</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="57"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Received Assigned Intervention</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
                <participants group_id="P2" count="57"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Confirmed Diagnosis by Physician</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="39"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="39"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Re-randomization for Treatment</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="39"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="29"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Not appropriate</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Laboratory Testing</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="6">From interdisciplinary (4) or standard (2) evaluation from Period 1</participants>
                <participants group_id="P4" count="6">From interdisciplinary (4) or standard (2) evaluation from Period 1</participants>
                <participants group_id="P5" count="7">From interdisciplinary (4) or standard (3) evaluation from Period 1</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Baseline Lab Testing</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The participants who met all eligibility criteria and had non-arthritic hip disease diagnosed by the physician were included.</population>
      <group_list>
        <group group_id="B1">
          <title>Interdisciplinary Evaluation</title>
          <description>Participants will receive an Interdisciplinary Evaluation for Nonarthritic Hip Disease from a hip arthroscopist, followed by an examination from a physical therapist, and then will participate in a shared decision-making process with both providers to determine a plan of care.
Interdisciplinary Evaluation for Nonarthritic Hip Disease: The hip arthroscopist will conduct his or her standard-care evaluation including subjective interview, patient history, imaging, and physical examination. The physical therapist will conduct an assessment of posture and movement during sitting, standing, squatting, and walking. After providers discuss their findings, they will discuss the plan of care with the participant.</description>
        </group>
        <group group_id="B2">
          <title>Standard Evaluation</title>
          <description>Participants will receive a standard-of-care evaluation from a hip arthroscopist who will then determine the plan of care with the participant.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="39"/>
            <count group_id="B2" value="39"/>
            <count group_id="B3" value="78"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36" spread="10"/>
                    <measurement group_id="B2" value="41" spread="11"/>
                    <measurement group_id="B3" value="38" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Decisional Conflict</title>
          <description>Decisional conflict was measured using the Decisional Conflict Scale ranging from 0 (no conflict, better outcome) to 100 (high conflict, worse outcome).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.0" spread="19.6"/>
                    <measurement group_id="B2" value="40.1" spread="18.6"/>
                    <measurement group_id="B3" value="37.6" spread="19.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Treatment Plan</title>
        <description>Participants will indicate their planned treatment(s)</description>
        <time_frame>Post-evaluation, same-day (approximately 5-10min after evaluation)</time_frame>
        <population>Participants from Period 1 (Clinic evaluation) were analyzed for this primary outcome measure based on interdisciplinary or standard evaluation. This outcome measure was not a planned outcome for Period 3 (Laboratory testing) and thus, values are not reported for posture and movement training, 3-week wait period, or observational groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Interdisciplinary Evaluation</title>
            <description>Participants will receive an Interdisciplinary Evaluation for Nonarthritic Hip Disease from a hip arthroscopist, followed by an examination from a physical therapist, and then will participate in a shared decision-making process with both providers to determine a plan of care.
Interdisciplinary Evaluation for Nonarthritic Hip Disease: The hip arthroscopist will conduct his or her standard-care evaluation including subjective interview, patient history, imaging, and physical examination. The physical therapist will conduct an assessment of posture and movement during sitting, standing, squatting, and walking. After providers discuss their findings, they will discuss the plan of care with the participant.</description>
          </group>
          <group group_id="O2">
            <title>Standard Evaluation</title>
            <description>Participants will receive a standard-of-care evaluation from a hip arthroscopist who will then determine the plan of care with the participant.</description>
          </group>
          <group group_id="O3">
            <title>Posture and Movement Training</title>
            <description>Participants will receive six training sessions with a physical therapist over a 3-week period.</description>
          </group>
          <group group_id="O4">
            <title>3-week Wait Period</title>
            <description>Participants will undergo a 3-week wait period. They will be instructed to not receive any treatment (e.g. chiropractic services, physical therapy, medication, surgery, injections) for their hip symptoms during this time.</description>
          </group>
          <group group_id="O5">
            <title>Observational Arm</title>
            <description>Participants who refuse randomization to receive posture and movement training may continue participation in an observational group. These participants complete the same baseline and follow-up testing but proceed with their treatment-of-choice during the 3-week intervention period.</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Plan</title>
          <description>Participants will indicate their planned treatment(s)</description>
          <population>Participants from Period 1 (Clinic evaluation) were analyzed for this primary outcome measure based on interdisciplinary or standard evaluation. This outcome measure was not a planned outcome for Period 3 (Laboratory testing) and thus, values are not reported for posture and movement training, 3-week wait period, or observational groups.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Physical Therapy included in treatment plan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Surgery included in treatment plan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection included in treatment plan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Decisional Conflict</title>
        <description>Participants will report decisional conflict related to their treatment plan. Decisional conflict was measured using the Decisional Conflict Scale ranging from 0 (no conflict, better outcome) to 100 (high conflict, worse outcome).</description>
        <time_frame>Pre-evaluation, 10min Post-evaluation</time_frame>
        <population>Participants from Period 1 (Clinic evaluation) were analyzed for this primary outcome measure based on interdisciplinary or standard evaluation. This outcome measure was not a planned outcome for Period 3 (Laboratory testing) and thus, values are not reported for posture and movement training, 3-week wait period, or observational groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Interdisciplinary Evaluation</title>
            <description>Participants will receive an Interdisciplinary Evaluation for Nonarthritic Hip Disease from a hip arthroscopist, followed by an examination from a physical therapist, and then will participate in a shared decision-making process with both providers to determine a plan of care.
Interdisciplinary Evaluation for Nonarthritic Hip Disease: The hip arthroscopist will conduct his or her standard-care evaluation including subjective interview, patient history, imaging, and physical examination. The physical therapist will conduct an assessment of posture and movement during sitting, standing, squatting, and walking. After providers discuss their findings, they will discuss the plan of care with the participant.</description>
          </group>
          <group group_id="O2">
            <title>Standard Evaluation</title>
            <description>Participants will receive a standard-of-care evaluation from a hip arthroscopist who will then determine the plan of care with the participant.</description>
          </group>
          <group group_id="O3">
            <title>Posture and Movement Training</title>
            <description>Participants will receive six training sessions with a physical therapist over a 3-week period.</description>
          </group>
          <group group_id="O4">
            <title>3-week Wait Period</title>
            <description>Participants will undergo a 3-week wait period. They will be instructed to not receive any treatment (e.g. chiropractic services, physical therapy, medication, surgery, injections) for their hip symptoms during this time.</description>
          </group>
          <group group_id="O5">
            <title>Observational Arm</title>
            <description>Participants who refuse randomization to receive posture and movement training may continue participation in an observational group. These participants complete the same baseline and follow-up testing but proceed with their treatment-of-choice during the 3-week intervention period.</description>
          </group>
        </group_list>
        <measure>
          <title>Decisional Conflict</title>
          <description>Participants will report decisional conflict related to their treatment plan. Decisional conflict was measured using the Decisional Conflict Scale ranging from 0 (no conflict, better outcome) to 100 (high conflict, worse outcome).</description>
          <population>Participants from Period 1 (Clinic evaluation) were analyzed for this primary outcome measure based on interdisciplinary or standard evaluation. This outcome measure was not a planned outcome for Period 3 (Laboratory testing) and thus, values are not reported for posture and movement training, 3-week wait period, or observational groups.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-evaluation decisional conflict</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.0" spread="19.6"/>
                    <measurement group_id="O2" value="40.1" spread="18.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-evaluation decisional conflict</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.2" spread="11.2"/>
                    <measurement group_id="O2" value="16.5" spread="13.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Themes From Provider Interviews</title>
        <description>Qualitative interviews will be conducted with study providers both before patient participant enrollment and after study completion to collect information on how they feel about the evaluation protocols. Qualitative analysis of this data will count responses based on themes. Data for this report will be provided as the total number of responses (across all providers) that fell within each theme at both time points. Each provider could provide multiple responses.</description>
        <time_frame>Pre-enrollment (2-7days before patient participant recruitment began), Post-enrollment (1-7 days after patient participant recruitment ended)</time_frame>
        <population>The orthopaedic surgeons (n=2) and one physical therapist (n=1) from the study were interviewed and number of responses during the interviews were totaled based on theme. Each provider could have multiple responses. These providers are not associated with a specific arm or group of patient participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Pre-enrollment</title>
            <description>The orthopaedic surgeons (2) and physical therapist (1) who participated as study clinicians were interviewed regarding their opinions of the interdisciplinary evaluation.</description>
          </group>
          <group group_id="O2">
            <title>Post-enrollment</title>
            <description>The orthopaedic surgeons (2) and physical therapist (1) who participated as study clinicians were interviewed regarding their opinions of the interdisciplinary evaluation.</description>
          </group>
        </group_list>
        <measure>
          <title>Themes From Provider Interviews</title>
          <description>Qualitative interviews will be conducted with study providers both before patient participant enrollment and after study completion to collect information on how they feel about the evaluation protocols. Qualitative analysis of this data will count responses based on themes. Data for this report will be provided as the total number of responses (across all providers) that fell within each theme at both time points. Each provider could provide multiple responses.</description>
          <population>The orthopaedic surgeons (n=2) and one physical therapist (n=1) from the study were interviewed and number of responses during the interviews were totaled based on theme. Each provider could have multiple responses. These providers are not associated with a specific arm or group of patient participants.</population>
          <units>number of responses for each theme</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Implementation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Interdisciplinary Evaluation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patient Response</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clinical Reasoning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Environment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participant Protocol Opinions</title>
        <description>Participants will be interviewed to collect information on how they feel about the 1) evaluation protocol(s) and 2) treatment/wait period protocols.</description>
        <time_frame>20min post-evaluation, 4 weeks post-evaluation</time_frame>
        <population>Data were not collected.</population>
        <group_list>
          <group group_id="O1">
            <title>Interdisciplinary Evaluation</title>
            <description>Participants will receive an Interdisciplinary Evaluation for Nonarthritic Hip Disease from a hip arthroscopist, followed by an examination from a physical therapist, and then will participate in a shared decision-making process with both providers to determine a plan of care.
Interdisciplinary Evaluation for Nonarthritic Hip Disease: The hip arthroscopist will conduct his or her standard-care evaluation including subjective interview, patient history, imaging, and physical examination. The physical therapist will conduct an assessment of posture and movement during sitting, standing, squatting, and walking. After providers discuss their findings, they will discuss the plan of care with the participant.</description>
          </group>
          <group group_id="O2">
            <title>Standard Evaluation</title>
            <description>Participants will receive a standard-of-care evaluation from a hip arthroscopist who will then determine the plan of care with the participant.</description>
          </group>
          <group group_id="O3">
            <title>Posture and Movement Training</title>
            <description>Participants will receive six training sessions with a physical therapist over a 3-week period.</description>
          </group>
          <group group_id="O4">
            <title>3-week Wait Period</title>
            <description>Participants will undergo a 3-week wait period. They will be instructed to not receive any treatment (e.g. chiropractic services, physical therapy, medication, surgery, injections) for their hip symptoms during this time.</description>
          </group>
          <group group_id="O5">
            <title>Observational Arm</title>
            <description>Participants who refuse randomization to receive posture and movement training may continue participation in an observational group. These participants complete the same baseline and follow-up testing but proceed with their treatment-of-choice during the 3-week intervention period.</description>
          </group>
        </group_list>
        <measure>
          <title>Participant Protocol Opinions</title>
          <description>Participants will be interviewed to collect information on how they feel about the 1) evaluation protocol(s) and 2) treatment/wait period protocols.</description>
          <population>Data were not collected.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Decisional Conflict</title>
        <description>Participants will report decisional conflict related to their treatment plan. Decisional conflict was measured using the Decisional Conflict Scale ranging from 0 (no conflict, better outcome) to 100 (high conflict, worse outcome). Baseline scores for participants in Period 3 (Laboratory testing) were obtained from participants' post-evaluation surveys from Period 1 (clinic evaluation).</description>
        <time_frame>10min post-evaluation, 4-week laboratory visit</time_frame>
        <population>Participants from Period 3 (Laboratory testing) were analyzed for this secondary outcome measure based on treatment group (Posture &amp; movement training, wait period, or observational). This outcome measure was not a planned follow-up outcome for Period 1 (Clinic evaluation) and thus, values are not reported for interdisciplinary and standard groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Posture and Movement Training</title>
            <description>Participants will receive six training sessions with a physical therapist over a 3-week period.</description>
          </group>
          <group group_id="O2">
            <title>3-week Wait Period</title>
            <description>Participants will undergo a 3-week wait period. They will be instructed to not receive any treatment (e.g. chiropractic services, physical therapy, medication, surgery, injections) for their hip symptoms during this time.</description>
          </group>
          <group group_id="O3">
            <title>Observational Arm</title>
            <description>Participants who refuse randomization to receive posture and movement training may continue participation in an observational group. These participants complete the same baseline and follow-up testing but proceed with their treatment-of-choice during the 3-week intervention period.</description>
          </group>
          <group group_id="O4">
            <title>Interdisciplinary Evaluation</title>
            <description>Participants will receive an Interdisciplinary Evaluation for Nonarthritic Hip Disease from a hip arthroscopist, followed by an examination from a physical therapist, and then will participate in a shared decision-making process with both providers to determine a plan of care.
Interdisciplinary Evaluation for Nonarthritic Hip Disease: The hip arthroscopist will conduct his or her standard-care evaluation including subjective interview, patient history, imaging, and physical examination. The physical therapist will conduct an assessment of posture and movement during sitting, standing, squatting, and walking. After providers discuss their findings, they will discuss the plan of care with the participant.</description>
          </group>
          <group group_id="O5">
            <title>Standard Evaluation</title>
            <description>Participants will receive a standard-of-care evaluation from a hip arthroscopist who will then determine the plan of care with the participant.</description>
          </group>
        </group_list>
        <measure>
          <title>Decisional Conflict</title>
          <description>Participants will report decisional conflict related to their treatment plan. Decisional conflict was measured using the Decisional Conflict Scale ranging from 0 (no conflict, better outcome) to 100 (high conflict, worse outcome). Baseline scores for participants in Period 3 (Laboratory testing) were obtained from participants' post-evaluation surveys from Period 1 (clinic evaluation).</description>
          <population>Participants from Period 3 (Laboratory testing) were analyzed for this secondary outcome measure based on treatment group (Posture &amp; movement training, wait period, or observational). This outcome measure was not a planned follow-up outcome for Period 1 (Clinic evaluation) and thus, values are not reported for interdisciplinary and standard groups.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Post-evaluation decisional conflict</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.2" spread="10.3"/>
                    <measurement group_id="O2" value="14.8" spread="20.9"/>
                    <measurement group_id="O3" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4-week decisional conflict</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.0" spread="16.2"/>
                    <measurement group_id="O2" value="13.2" spread="9.9"/>
                    <measurement group_id="O3" value="0.0" spread="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient-reported Hip Function</title>
        <description>Participants will complete validated, reliable surveys for hip function (the Hip Outcome Score Activities of Daily Living [HOSADL] was used and is scored from 0-100 with 0 representing the worst function and 100 representing the best function). Baseline scores for participants in Period 3 (Laboratory testing) were obtained from participants' post-evaluation surveys from Period 1 (clinic evaluation).</description>
        <time_frame>10min post-evaluation, 4-week laboratory visit</time_frame>
        <population>Participants from Period 3 (Laboratory testing) were analyzed for this secondary outcome measure based on treatment group (Posture &amp; movement training, wait period, or observational). This outcome measure was not a planned follow-up outcome for Period 1 (Clinic evaluation) and thus, values are not reported for interdisciplinary and standard groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Posture and Movement Training</title>
            <description>Participants will receive six training sessions with a physical therapist over a 3-week period.</description>
          </group>
          <group group_id="O2">
            <title>3-week Wait Period</title>
            <description>Participants will undergo a 3-week wait period. They will be instructed to not receive any treatment (e.g. chiropractic services, physical therapy, medication, surgery, injections) for their hip symptoms during this time.</description>
          </group>
          <group group_id="O3">
            <title>Observational Arm</title>
            <description>Participants who refuse randomization to receive posture and movement training may continue participation in an observational group. These participants complete the same baseline and follow-up testing but proceed with their treatment-of-choice during the 3-week intervention period.</description>
          </group>
          <group group_id="O4">
            <title>Interdisciplinary Evaluation</title>
            <description>Participants will receive an Interdisciplinary Evaluation for Nonarthritic Hip Disease from a hip arthroscopist, followed by an examination from a physical therapist, and then will participate in a shared decision-making process with both providers to determine a plan of care.
Interdisciplinary Evaluation for Nonarthritic Hip Disease: The hip arthroscopist will conduct his or her standard-care evaluation including subjective interview, patient history, imaging, and physical examination. The physical therapist will conduct an assessment of posture and movement during sitting, standing, squatting, and walking. After providers discuss their findings, they will discuss the plan of care with the participant.</description>
          </group>
          <group group_id="O5">
            <title>Standard Evaluation</title>
            <description>Participants will receive a standard-of-care evaluation from a hip arthroscopist who will then determine the plan of care with the participant.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient-reported Hip Function</title>
          <description>Participants will complete validated, reliable surveys for hip function (the Hip Outcome Score Activities of Daily Living [HOSADL] was used and is scored from 0-100 with 0 representing the worst function and 100 representing the best function). Baseline scores for participants in Period 3 (Laboratory testing) were obtained from participants' post-evaluation surveys from Period 1 (clinic evaluation).</description>
          <population>Participants from Period 3 (Laboratory testing) were analyzed for this secondary outcome measure based on treatment group (Posture &amp; movement training, wait period, or observational). This outcome measure was not a planned follow-up outcome for Period 1 (Clinic evaluation) and thus, values are not reported for interdisciplinary and standard groups.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Post-evaluation HOSADL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.9" spread="21.7"/>
                    <measurement group_id="O2" value="72.6" spread="29.8"/>
                    <measurement group_id="O3" value="89.0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4-week HOSADL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.2" spread="20.0"/>
                    <measurement group_id="O2" value="77.2" spread="25.9"/>
                    <measurement group_id="O3" value="92.6" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Movement Mechanics</title>
        <description>3-dimensional movement mechanics will be collected during functional tasks including walking and rising from a chair</description>
        <time_frame>Baseline laboratory visit, 4-week laboratory visit</time_frame>
        <population>Movement mechanics were not a planned variable for Period 1 (Clinic evaluation), but were a planned secondary variable for Period 3 (Laboratory testing). Collected data for the 7 participants who completed 4-week testing required extensive processing and resources that were not available due to loss of funding and personnel.</population>
        <group_list>
          <group group_id="O1">
            <title>Posture and Movement Training</title>
            <description>Participants will receive six training sessions with a physical therapist over a 3-week period.</description>
          </group>
          <group group_id="O2">
            <title>3-week Wait Period</title>
            <description>Participants will undergo a 3-week wait period. They will be instructed to not receive any treatment (e.g. chiropractic services, physical therapy, medication, surgery, injections) for their hip symptoms during this time.</description>
          </group>
          <group group_id="O3">
            <title>Observational Arm</title>
            <description>Participants who refuse randomization to receive posture and movement training may continue participation in an observational group. These participants complete the same baseline and follow-up testing but proceed with their treatment-of-choice during the 3-week intervention period.</description>
          </group>
          <group group_id="O4">
            <title>Interdisciplinary Evaluation</title>
            <description>Participants will receive an Interdisciplinary Evaluation for Nonarthritic Hip Disease from a hip arthroscopist, followed by an examination from a physical therapist, and then will participate in a shared decision-making process with both providers to determine a plan of care.
Interdisciplinary Evaluation for Nonarthritic Hip Disease: The hip arthroscopist will conduct his or her standard-care evaluation including subjective interview, patient history, imaging, and physical examination. The physical therapist will conduct an assessment of posture and movement during sitting, standing, squatting, and walking. After providers discuss their findings, they will discuss the plan of care with the participant.</description>
          </group>
          <group group_id="O5">
            <title>Standard Evaluation</title>
            <description>Participants will receive a standard-of-care evaluation from a hip arthroscopist who will then determine the plan of care with the participant.</description>
          </group>
        </group_list>
        <measure>
          <title>Movement Mechanics</title>
          <description>3-dimensional movement mechanics will be collected during functional tasks including walking and rising from a chair</description>
          <population>Movement mechanics were not a planned variable for Period 1 (Clinic evaluation), but were a planned secondary variable for Period 3 (Laboratory testing). Collected data for the 7 participants who completed 4-week testing required extensive processing and resources that were not available due to loss of funding and personnel.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Decisional Regret</title>
        <description>Participants will report decision regret related to their treatment plans</description>
        <time_frame>Day of enrollment, after all evaluations are complete</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Decisional Regret</title>
        <description>Participants will report decision regret related to their treatment plans</description>
        <time_frame>4 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Changes in Hip Strength</title>
        <description>Strength of hip abductors, adductors, flexors, extenders, internal and external rotators will be collected during maximal voluntary isometric contractions</description>
        <time_frame>4 weeks</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected throughout the 15-month recruitment period and up to the 4-week follow-up for any participants who underwent treatment as part of the trial.</time_frame>
      <desc>Adverse events were defined per the clinicaltrials.gov definitions. Adverse events that were (1) reported by participants to study personnel or study clinicians or (2) identified by study personnel or study clinicians were recorded.</desc>
      <group_list>
        <group group_id="E1">
          <title>Interdisciplinary Evaluation</title>
          <description>Participants will receive an Interdisciplinary Evaluation for Nonarthritic Hip Disease from a hip arthroscopist, followed by an examination from a physical therapist, and then will participate in a shared decision-making process with both providers to determine a plan of care.
Interdisciplinary Evaluation for Nonarthritic Hip Disease: The hip arthroscopist will conduct his or her standard-care evaluation including subjective interview, patient history, imaging, and physical examination. The physical therapist will conduct an assessment of posture and movement during sitting, standing, squatting, and walking. After providers discuss their findings, they will discuss the plan of care with the participant.</description>
        </group>
        <group group_id="E2">
          <title>Standard Evaluation</title>
          <description>Participants will receive a standard-of-care evaluation from a hip arthroscopist who will then determine the plan of care with the participant.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="39"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="39"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="39"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Seventy-eight (78) participants were included from the 15-month recruitment period (81% of the target n=96). Randomization for interdisciplinary vs. standard evaluation had to occur before physician evaluation, modified from the original protocol.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Stephanie Di Stasi</name_or_title>
      <organization>The Ohio State University</organization>
      <phone>614-685-9779</phone>
      <email>stephanie.distasi@osumc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

